The Foundation
We are working to defeat this disease and achieve a future in which aging is associated with positive experiences.
For three days, we have organised a series of informative talks to explain the projects we carry out in the entity, as well as the different infrastructures that comprise it.
The work, led by the BBRC and published in the journal Alzheimer's & Dementia, has been key to getting the European Medicines Agency to approve this metric as a valid biomarker for Alzheimer's disease.
This year, nearly 700 people have signed up for the charity march to raise funds for Alzheimer's.
Participation, which can be online or in person, includes a donation of €1 that will go towards our research projects.
During the meeting, we had the opportunity to present the different Alzheimer's projects that we carry out at our facilities.
New therapies are needed to prevent or delay the onset of symptoms, slow disease progression, or improve cognitive and behavioral symptoms of Alzheimer's disease.
We attended the 34th Alzheimer Europe Conference under the motto "New horizons: innovating for dementia" to present some of our social, informative and scientific projects.
The study, led by Dr. Laura García González, postdoctoral researcher of the Genomics Research Group at the Barcelonaßeta Brain Research Center, analyzes the biological and genetic mechanisms of Alzheimer's disease.
Through the Ambassador Partner Program, we want to work with participatory processes in which they can be an active part of the Foundation.
Under the motto "We make science happen", the open day of the Barcelona Biomedical Research Park seeks to raise awareness on the street about the activities of the centres that make up the Park.
The second call for proposals of the Pasqual Maragall Researchers Programme (PMRP) will distribute a total of 1.6 million euros between the two selected projects.
Nearly 100 people participated in the informative session we held on the prevention of Alzheimer's through the adoption of healthy lifestyle habits.